Neveen A. Hussein

Neveen A. Hussein

Auto-generated profile, based on publicly available information

Neveen A. Hussein

Applied Medical Chemistry Department, Medical Research Institute, Alexandria University, Alexandria, Egypt

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2016 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
NHNeveen Abd El Moneim Hussein
Neveen Abd El Moneim Hussein
ZKZenat A. El Kholy
Zenat A. El Kholy
MAMedhat M. Anwar
Medhat M. Anwar
MAMohamed A. Ahmad
Mohamed A. Ahmad
SAShaymaa M. Ahmad
Shaymaa M. Ahmad

24 December 2010 in Journal of Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
MMMagda Mohasseb
Magda Mohasseb
SESamia Ebied
Samia Ebied
MYMona Yehia
Mona Yehia
NHNeveen Hussein
Neveen Hussein

28 August 2018 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
NHNeveen A. Hussein
Neveen A. Hussein
SMSalwa N. Mohamed
Salwa N. Mohamed
MAMohamed A. Ahmed
Mohamed A. Ahmed

28 November 2013 in Hematology
Verified
Journal Article
Closed access
MEMervat A. El-Tokhy
Mervat A. El-Tokhy
NHNeveen A. Hussein
Neveen A. Hussein
ABAhmed M. L. Bedewy
Ahmed M. L. Bedewy
MBMohammad R. Barakat
Mohammad R. Barakat
Cytogenetically normal acute myeloid leukemia (AML) represents nearly half of newly diagnosed de novo AML cases. XPD is one of the DNA repair proteins, whose genetic polymorphisms are thought to affect their function as regards response to chemotherapeutic drugs and chemotherapy-induced toxicities. We investigated the XPD Asp312Asn and Lys751Gln polymorphisms by polymerase chain reaction-restriction fragment length polymorphism in 51 newly diagnosed cytogenetically normal de novo AML patients. The response to the standard induction chemotherapy protocol and chemotherapy-induced toxicities were monitored. The XPD Asp312Asn GG genotype was the most frequent (57%) followed by the GA variant (37%), and the AA variant was the least frequent (6%). As regards the XPD Lys751Gln polymorphism, the AA genotype was the most frequent (49%), followed by the AC (39%) and CC (12%) variants. These variants were not associated with age, sex, FAB subtype, CNS infiltration, chemotherapy-induced hepatotoxicity, nephrotoxicity, or metabolic toxicity. The XPD Lys751Gln CC polymorphic variant was associated with chemotherapy-induced cardiotoxicity and lower chance to achieve response to induction chemotherapy. XPD Lys751Gln and not Asp312Asn polymorphism was associated with chemotherapy-induced cardiotoxicity and response to induction chemotherapy in newly diagnosed cytogenetically normal AML patients. Pretreatment assay of XPD Lys751Gln may help to anticipate cardiotoxicity in those at risk. Moreover, it may be considered a prognostic marker in AML cases. However, further large scale research is needed to verify its usefulness.

16 August 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NHNeveen A. Hussein
Neveen A. Hussein
SSShehata M. El Sewedy
Shehata M. El Sewedy
MZMohamed M. Zakareya
Mohamed M. Zakareya
EYEngy A. Youssef
Engy A. Youssef
FIFawziya A. R. Ibrahim
Fawziya A. R. Ibrahim
Colorectal cancer (CRC) poses a significant burden on both the healthcare systems as well as individuals. The high mortality rate of CRC may be attributed to its metastatic potential, heterogeneity, and delayed diagnosis. CircRNAs are an essential class of regulatory RNAs that play significant roles in cancers. This study aimed to detect the expression status of circ-SMARCA5, circ-NOL10, circ-LDLRAD3, and circ-RHOT1 in patients with CRC. This study included 50 CRC patients, 30 individuals with colorectal diseases (non-cancer), and 20 healthy volunteers. By using real-time PCR, the relative expression of circ-SMARCA5, circ-NOL10, circ-LDLRAD3, and circ-RHOT1 was determined in the collected blood samples. In addition, ECLIA was used to quantify carcinoembryonic antigen (CEA) level. All circRNAs expression and CEA levels were significantly up-regulated in cancer patients (CRC, colon, rectum) as compared to healthy controls, except circ-SMARCA5. Moreover, there was a significant up-regulation of circRNAs in most non-cancer patients (UC, polyp, piles). Insignificant upregulation was observed in circRNAs and CEA when comparing cancer with non-cancer patients. No correlations were found between the studied parameters and most clinicopathological characteristics of cancer and non-cancer patients. Circ-SMARCA5, circ-NOL10, circ-LDLRAD3, and circ-RHOT1 were differentially expressed in patients with CRC as well as in non-cancer patients. Circ-SMARCA5 and circ-NOL10 may act as tumor suppressors, while circ-LDLRAD3 and circ-RHOT1 may be oncogenes. Circ-SMARCA5, circ-NOL10, circ-LDLRAD3, and circ-RHOT1 could be promising markers for the early detection of CRC.

8 April 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NHNeveen A. Hussein
Neveen A. Hussein
SESamia A. Ebid
Samia A. Ebid
MAMohammad A. Ahmad
Mohammad A. Ahmad
GKGamal E. Khedr
Gamal E. Khedr
DSDina M. Saad
Dina M. Saad
MicroRNAs are small RNA molecules that have a significant role in translational repression and gene silencing through binding to downstream target mRNAs. MiR-762 can stimulate the proliferation and metastasis of various types of cancer. Hippo pathway is one of the pathways that regulate tissue development and carcinogenesis. Dysregulation of this pathway plays a vital role in the progression of cancer. This study aimed to evaluate the possible correlation between miR-762, the Hippo signaling pathway, TWIST1, and SMAD3 in patients with lung cancer, as well as patients with chronic inflammatory diseases. The relative expression of miR-762, MST1, LATS2, YAP, TWIST1, and SMAD3 was determined in 50 lung cancer patients, 30 patients with chronic inflammatory diseases, and 20 healthy volunteers by real-time PCR. The levels of YAP protein and neuron-specific enolase were estimated by ELISA and electrochemiluminescence immunoassay, respectively. Compared to the control group, miR-762, YAP, TWIST1, and SMAD3 expression were significantly upregulated in lung cancer patients and chronic inflammatory patients, except SMAD3 was significantly downregulated in chronic inflammatory patients. MST1, LATS2, and YAP protein were significantly downregulated in all patients. MiR-762 has a significant negative correlation with MST1, LATS2, and YAP protein in lung cancer patients and with MST1 and LATS2 in chronic inflammatory patients. MiR-762 may be involved in the induction of malignant behaviors in lung cancer through suppression of the Hippo pathway. MiR-762, MST1, LATS2, YAP mRNA and protein, TWIST1, and SMAD3 may be effective diagnostic biomarkers in both lung cancer patients and chronic inflammatory patients. High YAP, TWIST1, SMA3 expression, and NSE level are associated with a favorable prognosis for lung cancer.